Rare diseases
Investigational molecules
Locations
Back to Slovakia25 clinical trials in Stare Mesto, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
SlovakiaStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
SlovakiaStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
SlovakiaEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SlovakiaA Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
SlovakiaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
SlovakiaAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
SlovakiaA study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes
SlovakiaPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
SlovakiaStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
SlovakiaStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
SlovakiaStudy on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on obesity and cardiovascular health, evaluating innovative treatments for weight management and cardiovascular disease prevention.
Several trials are investigating novel compounds like survodutide and orforglipron for weight reduction and metabolic improvement.
Comprehensive research into multiple sclerosis and migraine treatments, exploring new therapeutic approaches for neurological conditions.
Studies include evaluations of atogepant for migraine treatment and frexalimab for multiple sclerosis therapy.
Innovative research addressing Major Depressive Disorder and schizophrenia, testing new therapeutic combinations and treatment approaches.
Trials include testing seltorexant and aticaprant as adjunctive therapies for depression.
Specialized studies examining Thyroid Eye Disease and Sjögren's Syndrome, with focus on innovative biological treatments.
Research includes batoclimab trials for TED and danicopan studies for macular degeneration.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
